Integrated genomic and metabolomic analysis reveals the anti-inflammatory potential of Bifidobacterium animalis subsp. lactis BGI-N3 in DSS-induced colitis
Frontiers in Microbiology · 18.11.2026 · 17
DOI: 10.3389/fmicb.2026.1933134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 18.11.2026. Verfasst von Yangfeng Wen und 15 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Probiotics offer a promising therapeutic avenue for inflammatory bowel disease (IBD), yet their efficacy is highly strain-specific and mechanistically complex. To address this, this study integrated complete genome sequencing, in vitro assays, and in vivo metabolomics to elucidate the anti-inflammatory mechanisms of Bifidobacterium animalis subsp. lactis BGI-N3. Genomic analysis confirmed the presence of gene clusters associated with stress tolerance and immunomodulation. Functionally, BGI-N3 suppressed LPS-induced pro-inflammatory cytokines in monocytes and significantly alleviated DSS-induced colitis in mice by restoring mucosal architecture. Crucially, untargeted metabolomics demonstrated that BGI-N3 intervention restructured the gut metabolic landscape, specifically enriching anti-inflammatory metabolites, including ergocalciferol, vanillin, and dihomo-gamma-linolenic acid (DGLA). These metabolites correlated positively with IL-10 levels and negatively with pro-inflammatory markers. Collectively, these findings provided genomic validation and insights into metabolic changes associated with the protective effects of BGI-N3, highlighting its potential as a functional probiotic for alleviating intestinal inflammation.
Zitieren
APA
Wen, Y., Liu, T., Wei, B., Cai, S., Zhang, P., Ma, Z., Xu, X., Liu, Y., Li, S., He, N., Sun, Y., Zhang, H., Xiao, L., Zou, Y., Luo, Q., & Zhong, Y. (2026). Integrated genomic and metabolomic analysis reveals the anti-inflammatory potential of Bifidobacterium animalis subsp. lactis BGI-N3 in DSS-induced colitis. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1933134
Vancouver
Wen Y, Liu T, Wei B, Cai S, Zhang P, Ma Z, et al. Integrated genomic and metabolomic analysis reveals the anti-inflammatory potential of Bifidobacterium animalis subsp. lactis BGI-N3 in DSS-induced colitis. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1933134
BibTeX
@article{Wen2026,
author = {Wen, Yangfeng and Liu, Tianli and Wei, Benliang and Cai, Sihang and Zhang, Peilin and Ma, Zhihui and Xu, Xiaowei and Liu, Yanhong and Li, Shangyong and He, Ningning and Sun, Yang and Zhang, Haifeng and Xiao, Liang and Zou, Yuanqiang and Luo, Qiang and Zhong, Yiyi},
title = {Integrated genomic and metabolomic analysis reveals the anti-inflammatory potential of Bifidobacterium animalis subsp. lactis BGI-N3 in DSS-induced colitis},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1933134}
}
EUVIMED